Your browser doesn't support javascript.
loading
Healthcare Resource Utilization, Exacerbations, and Readmissions Among Medicare Patients with Chronic Obstructive Pulmonary Disease After Long-Acting Muscarinic Antagonist Therapy Initiation with Soft Mist versus Dry Powder Inhalers.
Singer, David; Bengtson, Lindsay G S; Elliott, Caitlin; Buikema, Ami R; Franchino-Elder, Jessica.
Affiliation
  • Singer D; Health Economics and Outcomes Research, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA.
  • Bengtson LGS; Health Economics and Outcomes Research, Optum, Eden Prairie, MN, USA.
  • Elliott C; Health Economics and Outcomes Research, Optum, Eden Prairie, MN, USA.
  • Buikema AR; Health Economics and Outcomes Research, Optum, Eden Prairie, MN, USA.
  • Franchino-Elder J; Health Economics and Outcomes Research, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA.
Int J Chron Obstruct Pulmon Dis ; 15: 3239-3250, 2020.
Article in En | MEDLINE | ID: mdl-33324047
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Peloideterapia Main subject: Muscarinic Antagonists / Pulmonary Disease, Chronic Obstructive Type of study: Diagnostic_studies Country/Region as subject: America do norte Language: En Journal: Int J Chron Obstruct Pulmon Dis Year: 2020 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Peloideterapia Main subject: Muscarinic Antagonists / Pulmonary Disease, Chronic Obstructive Type of study: Diagnostic_studies Country/Region as subject: America do norte Language: En Journal: Int J Chron Obstruct Pulmon Dis Year: 2020 Type: Article Affiliation country: United States